அரிது
அரிது, மானிடராய் பிறத்தல் அரிது; மானிடராய் பிறந்த காலையின் கூன் குருடு செவிடு நீங்கி
பிறத்தல் அரிது ~ the immortal words of Tamil
Poetess Avvaiyar. It means it is
difficult (rare) to be born as a human being; having been born – it is rare to
be a birth devoid of physical challenges like dumb, deaf, blind …. the significance
is that one should use appropriately such good birth and do good to the
Society.
The life of blind
is very tough. Blindness is a lack of vision. Various scales have been developed to describe
the extent of vision loss and define blindness. Total blindness is the complete
lack of form and visual light perception and is clinically recorded as NLP, an
abbreviation for "no light perception." Blindness is defined by the World Health
Organization as vision in a person's best eye of less than 20/500 or a visual
field of less than 10 degrees.
AnthahakKavi
– a reference to a well known poet who lived in 17th century –
Veeraraghava Mudaliyar, known so due to his vision impairment. He was blind from birth, yet established a
mark in Tamil literary World distinguishing himself with his poetic talents and
erudition. John Milton (1608 – 1674) a
Civil servant in England is better known as the great poet. He wrote at a time
of religious flux and political upheaval, and is best known for his epic poem
Paradise Lost (1667). By 1654, Milton
had become totally blind; the cause of his blindness is debated but bilateral
retinal detachment or glaucoma are most likely. His blindness forced him to
dictate his verse and prose to amanuenses (helpers), one of whom was the poet
Andrew Marvell. Milton's magnum opus, Paradise Lost, was composed by the blind
and impoverished Milton and by some accounts, the poem reflects his personal despair at the
failure of the Revolution, yet affirms an ultimate optimism in human potential.
In 1671, Milton published ‘Paradise regained’
– emphasising the idea of reversals. As
implied by its title, Milton sets out to reverse the "loss" of
Paradise. Thus, antonyms are often found next to each other, reinforcing the
idea that everything that was lost in the first epic will be regained by the
end of this "brief epic."
The
troubles of ‘visually challenged people’
are too well known – and there are very many ways by which we can be of some
help, mitigating their trouble. The
eternal challenge for Science is a cure for blindness. MailOnline queries on whether Scientists have
found a cure and whether radical gene therapy that restores sight in mice and
dogs could be used on humans. The post reveals
that a radical form of gene therapy that
remodels eye cells into light receptors has allowed scientists to partially
restore the sight of animals with inherited blindness. Scientists say the same
technique could one day be used to treat people with retinitis pigmentosa - an
inherited condition resulting in progressive loss of sight. In early tests on
blind rescue dogs with a similar condition, showed they could restore
sufficient light sensitivity for the animals to distinguish between flashing
and non-flashing lights. In normal mice with working photoreceptors,
stimulating the retina produced a variety of responses in retinal ganglion
cells, the output of the eye. Photoswitches inserted into retinal ganglion
cells (RGC) of blind mice produce much less variety of response (all evenly red
means the cells fire at the same time), while blind mice with photoswitches
inserted into bipolar cells (ON-BC driven) exhibit much more variety in their
retinal response to light, closer to that of normal mice.
Blind mice given
the same treatment became as good at navigating a water maze as normal mice. Two
components of the 'hybrid' treatment involve a gene that alters non-light
sensitive cells and an injected chemical 'photoswitch'. 'The dog has a retina
very similar to ours, much more so than mice, so when you want to bring a
visual therapy to the clinic, you want to first show that it works in a large
animal model of the disease,' said Professor Ehud Isacoff, lead research from
the University of California, Berkeley. The therapy is one of a number of
potential treatments for blindness at early stages of development, two of which
yielded exciting trial results this year. In October scientists from the
Massachusetts –based company Ocata Therapeutics, formerly known as Advanced Cell
Technology, showed that stem cell-derived retinal cells could safely be
implanted into patients and improve vision in some cases. Earlier this year
scientists at Oxford University hailed trial results from a genetic therapy for
choroideremia, a rare inherited cause of blindness that affects one in 50,000
people.
The new treatment
uses a virus to insert a gene into normally these cells in the retina that
gives them the potential to 'see'. The gene makes a protein that acts like a
lock. When the right molecular key from the photoreceptor switch is slotted
into the lock, light sensitivity is turned on. The therapy is said to show
promise because although diseases such as RP destroy the eye's photosensitive
cells, other cells in the retina are often left intact and unharmed.
Scientists
say the technique could one day be used to treat people with retinitis
pigmentosa - an inherited condition resulting in progressive loss of sight ~
that provides great hope to humanity.
With regards – S.
Sampathkumar
17th Dec
2014.
Retinitis pigmentosa is an inherited, degenerative eye disease that causes server to profound vision impairments including blindness. The condition is highly variable with some people showing symptoms in childhood and others are not aware of their condition until later in life. Emergency therapy and retinitis pigmentosa treatment should be taken.
ReplyDelete